A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30

Grant

Total Award Amount

  • 73267.00
  • Direct Costs

  • 72983.00
  • Sponsor Award Id

  • 657K672